Skip to main content
. 2017 Aug 24;8(44):77540–77551. doi: 10.18632/oncotarget.20560

Figure 2.

Figure 2

Distribution of clinicopathologic characteristics: tumor size, tumor grade, nodal status and pathologic response (A) disease-free (B) and overall survival (C) in cohort #1 according to T349C status. Patients with 349 T/C or C/C alleles had significantly shorter DFS and a trend toward a shorter OS.